ENDOXAN 1000 mg, poudre pour solution injectable — 1 flacon(s) en verre de 1000 mg

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400955837046
  • CIP7 5583704
  • CIS 69586327

What the source publishes

Holder
BAXTER
Active ingredients
CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE ANHYDRE
Form
poudre pour solution injectable
Package
1 flacon(s) en verre de 1000 mg
Routes
intramusculaire, intraveineuse
Administrative status
authorised
Supply regime
médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
Marketing status
Déclaration de commercialisation
Authorised on
1994-04-25
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400955837046
{
  "cis": "69586327",
  "cip7": "5583704",
  "form": "poudre pour solution injectable",
  "name": "ENDOXAN 1000 mg, poudre pour solution injectable — 1 flacon(s) en verre de 1000 mg",
  "cip13": "3400955837046",
  "holder": "BAXTER",
  "routes": [
    "intramusculaire",
    "intraveineuse"
  ],
  "holders": [
    "BAXTER"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": null,
  "authorisedOn": "1994-04-25",
  "compositions": [
    {
      "name": "CYCLOPHOSPHAMIDE",
      "nature": "SA",
      "strength": "1069,00 mg",
      "linkageNumber": "1",
      "substanceCode": "01556",
      "dosageReference": "un flacon",
      "pharmaceuticalElement": "poudre"
    },
    {
      "name": "CYCLOPHOSPHAMIDE ANHYDRE",
      "nature": "FT",
      "strength": "1000,00 mg",
      "linkageNumber": "1",
      "substanceCode": "77405",
      "dosageReference": "un flacon",
      "pharmaceuticalElement": "poudre"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
  "dispensingFee": null,
  "medicinePrice": null,
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "ENDOXAN 1000 mg, poudre pour solution injectable",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "1 flacon(s) en verre de 1000 mg",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [],
  "marketingDeclaredOn": "2003-04-22",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "CYCLOPHOSPHAMIDE",
    "CYCLOPHOSPHAMIDE ANHYDRE"
  ],
  "authorisationProcedure": "Procédure nationale",
  "prescriptionConditions": [
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
    "prescription réservée aux spécialistes et services HEMATOLOGIE",
    "prescription hospitalière",
    "liste I",
    "prescription réservée aux médecins compétents en CANCEROLOGIE"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400955837046"